Widespread distribution of reticulon-3 in various neurodegenerative diseasesNovel therapeutics for Alzheimer's disease: an updateLeptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's diseaseAntigen-antibody dissociation in Alzheimer disease: a novel approach to diagnosisDown-regulation of aminolevulinate synthase, the rate-limiting enzyme for heme biosynthesis in Alzheimer's diseaseSignaling effect of amyloid-beta(42) on the processing of AbetaPPHeme deficiency in Alzheimer's disease: a possible connection to porphyriaTau phosphorylation in Alzheimer's disease: pathogen or protector?Neuroprotective properties of Bcl-w in Alzheimer diseasePrion disease and Alzheimer's disease: pathogenic overlapPossible involvement of Wiskott-Aldrich syndrome protein family in aberrant neuronal sprouting in Alzheimer's disease.Down-regulation of serum gonadotropins but not estrogen replacement improves cognition in aged-ovariectomized 3xTg AD female miceDirect and indirect roles of cyclin-dependent kinase 5 as an upstream regulator in the c-Jun NH2-terminal kinase cascade: relevance to neurotoxic insults in Alzheimer's disease.A novel endogenous indole protects rodent mitochondria and extends rotifer lifespan.Insulin signaling, diabetes mellitus and risk of Alzheimer disease.Functional implications of antiestrogen induction of quinone reductase: inhibition of estrogen-induced deoxyribonucleic acid damage.Telomeres and telomerase in Alzheimer's disease: epiphenomena or a new focus for therapeutic strategy?Cell cycle re-entry and mitochondrial defects in myc-mediated hypertrophic cardiomyopathy and heart failure.Memantine: "hypothesis testing" not "disease modifying" in Alzheimer's diseaseDissociated amyloid-beta antibody levels as a serum biomarker for the progression of Alzheimer's disease: a population-based study.Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease.Nanoparticle and iron chelators as a potential novel Alzheimer therapy.Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment.Biomarkers in Alzheimer's disease: past, present and future.Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.Down-regulation of serum gonadotropins is as effective as estrogen replacement at improving menopause-associated cognitive deficits.Nanoparticle delivery of transition-metal chelators to the brain: Oxidative stress will never see it coming!Paraffin-embedded tissue (PET) blot method: application to Alzheimer disease.Alzheimer's disease: diverse aspects of mitochondrial malfunctioning.Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-betaLeptin: a novel therapeutic strategy for Alzheimer's diseaseMitochondrial Drugs for Alzheimer Disease.Antioxidant therapy in Alzheimer's disease: theory and practice.Pathological implications of cell cycle re-entry in Alzheimer disease.Mitochondria: the missing link between preconditioning and neuroprotection.A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease.Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies.LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's diseaseCauses versus effects: the increasing complexities of Alzheimer's disease pathogenesis.Early induction of oxidative stress in mouse model of Alzheimer disease with reduced mitochondrial superoxide dismutase activity.
P50
Q24610758-F81EC2FB-E692-4A69-828E-60841666FF9CQ24620383-86C33516-BBF6-4C3F-8B08-3C4F114F324BQ24630213-C0B16B47-FC70-4F85-A6D6-9DD9C02D721DQ24646892-71588DBF-ACA8-4847-A080-C560FDB367C8Q24654632-770B6BF8-F0A4-4FB9-A977-7913D4FC76FDQ24656147-53DF20D1-5F8A-4492-B6A4-9C42EC40372BQ28200784-9A6C6CF4-3E63-4CE3-8799-BB5A97FE23BEQ28244594-F00B3EB8-BDD8-45DD-9D1C-115A92B5C35AQ28262105-8F846C82-C252-4D88-BE45-BB574402A6C0Q28266468-0A01E2FE-9A98-4D39-A03A-B7FCBD6D40A8Q30164630-25FD0EB2-97C5-4C81-92F0-37883C099306Q30362093-7DDDE9EA-F0F7-4946-939C-A70CF63952EDQ30437355-F99325DD-988B-4325-8F65-876243503944Q30981817-36411107-D4E2-44DC-9181-AC9FAC1848B2Q30984271-936607E9-D678-4032-A77E-B9797BEE36C2Q31140537-D19D1F63-CB7F-4F85-9F53-FB1F48510070Q33347411-552C0AA2-3D34-47BD-8540-B7D61495BB31Q33506647-38E741B9-C6A3-445F-BFB3-6BFA3CAEE0B3Q33597031-CB4C05DC-7456-4AFF-A6FE-8EF568465320Q33625476-3BAD34BD-9DC9-4BD8-8549-8CD7B26FE554Q33674631-6EDDCB2A-CF86-471D-827A-30AFAE4F6947Q33720596-7F348881-BDC6-41C6-9825-A560FD076F1BQ33740552-6BA84C95-2ECE-46DE-B816-C5E758D9FEE1Q33791646-63FE5C4C-8C19-42C3-B60D-592490218212Q33897771-CDBE8A36-8CCA-4E5C-A4FF-DF78F8C84831Q33915170-A671E631-192C-4D2C-BE32-95411CBA3905Q33957213-B2F45821-3D2F-4A71-926A-9354C4BEF879Q34003234-2FE07E62-BAD9-4B38-9748-598663972C0BQ34007444-402ADBE9-92D3-45EF-8E78-0DB364F06C0EQ34009618-1F52BB92-F144-4D6E-B72B-A9B14505CB35Q34015256-90927B03-7A00-4571-B913-CB5C8E32F738Q34016406-DC1F1C0F-BDA3-47D0-AE8C-A42D25BCF6DEQ34066474-99ED2ADC-1CCD-4EF6-889C-D687BE39F83BQ34070765-DA201EFC-D10B-4FE2-9DD7-2C5AB78F66BCQ34073859-4637135F-78DF-4474-8EC4-8C4BFD5CAEF2Q34073879-61323488-F263-47F7-9711-B51263E0B520Q34073939-FA58376E-DA4B-4F30-8C66-6848BA5C6A7CQ34079774-4537B999-C800-45B0-A6F7-7295D36FBED1Q34112184-6AB18484-9B5F-4B7A-961C-184EE623BA29Q34140104-C714EEA3-F602-4988-B5CA-2D48D5C3BCC8
P50
description
American neuroscientist and Alzheimer researcher (1965-2010)
@en
Amerikaans neurowetenschapper (1965-2010)
@nl
neurocientífico estadounidense
@es
neurocientíficu estauxunidense (1965–2010)
@ast
neuroshkencëtar amerikan
@sq
neurosiensiste american
@lfn
usona neŭrosciencisto
@eo
عالم أعصاب من الولايات المتحدة الأمريكية
@ar
name
Mark A. Smith
@ast
Mark A. Smith
@ca
Mark A. Smith
@de
Mark A. Smith
@es
Mark A. Smith
@fr
Mark A. Smith
@it
Mark A. Smith
@nl
Mark A. Smith
@sl
Mark Anthony Smith
@en
مارك سميث
@ar
type
label
Mark A. Smith
@ast
Mark A. Smith
@ca
Mark A. Smith
@de
Mark A. Smith
@es
Mark A. Smith
@fr
Mark A. Smith
@it
Mark A. Smith
@nl
Mark A. Smith
@sl
Mark Anthony Smith
@en
مارك سميث
@ar
altLabel
Mark A. Smith
@en
prefLabel
Mark A. Smith
@ast
Mark A. Smith
@ca
Mark A. Smith
@de
Mark A. Smith
@es
Mark A. Smith
@fr
Mark A. Smith
@it
Mark A. Smith
@nl
Mark A. Smith
@sl
Mark Anthony Smith
@en
مارك سميث
@ar
P244
P268
P1053
A-9053-2009
P106
P1196
P19
P21
P213
0000 0000 1941 5688
P214
328144783016890843210
P244
n2013031838